Dr. Danny Sam, MD, FACP is an Adjunct Clinical Associate Professor in General Internal Medicine in the Department of Medicine at Boston University School of Medicine. Dr. Sam was born in San Francisco and moved to the East Coast where he graduated from the University of Maryland with a Bachelor’s degree in Chemistry. He then received his Medical Degree from Howard University School of Medicine in 1986. He completed his Internal Medicine Residency at LAC-USC (Los Angeles County-University of Southern California) Medical Center. Dr. Sam began his Internal Medicine Practice over 28 years ago at Kaiser Permanente Santa Clara, located in the heart of Silicon Valley.
As Dr. Sam’s career progressed, he became a module unit leader and developed the diabetes service, a multidisciplinary team that helped physicians and other care team members with patient management. Also, he is a member of the Departmental Peer Review Committee. The Departmental Peer Review Committee takes interesting or controversial cases, investigate them, learn from them what they can, and share this information. While Dr. Sam loves patient care, his primary passion has always been medical education. He joined Santa Clara’s residency program and taught residents and medical students, developed an Internal Medicine board review course, and became program director in 2004.
Later he became director of Graduate Medical Education. His team developed a primary care track called CHOICE, in which their residents could concentrate in areas like IT or community service. They partnered with the University of California, Davis School of Medicine in the development of a six-year medical school/residency primary care track, and more recently with Boston University to develop the Boston University-Kaiser Permanente Silicon Valley Regional Campus where each year, 16 third-year students from BU Medical School do their core clinical rotations at Kaiser Permanente Santa Clara and San Jose.
- Kaiser Permanente Santa Clara Medical Center
- Howard University, MD
- University of Maryland, MS
- University of Maryland, BS
- Published on 4/2/2019
Seto T, Pujare D, Song MN, Lee J, Huber R, Sam D, Pan M. Germline BRCA1 Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to Rucaparib. J Oncol Pract. 2019 May; 15(5):293-295. PMID: 30939057.
- Published on 3/18/2019
Seto T, Song MN, Trieu M, Yu J, Sidhu M, Liu CM, Sam D, Pan M. Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California. Med Sci (Basel). 2019 Mar 18; 7(3). PMID: 30889920.
- Published on 12/11/2017
Levy M, Lyon L, Barbero E, Wong J, Suga M, Sam D, Pan M. Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma. Med Sci (Basel). 2017 Dec 11; 5(4). PMID: 29232915.
- Published on 12/5/2017
Iribarren C, Sanchez G, Husson G, Levine-Hall T, Quesenberry C, Sam DL, Maier J, Chaudhary RS, Patel M, Sadeghi B, Javan H, Cho HM, Ding H, Molloi S. MultIethNic Study of BrEast ARterial Calcium Gradation and CardioVAscular Disease: cohort recruitment and baseline characteristics. Ann Epidemiol. 2018 01; 28(1):41-47.e12. PMID: 29246501.
- Published on 3/1/2017
Schmittdiel JA, Barrow JC, Wiley D, Ma L, Sam D, Chau CV, Shetterly SM. Improvements in access and care through the Affordable Care Act. Am J Manag Care. 2017 Mar 01; 23(3):e95-e97. PMID: 28385029.
- Published on 1/1/2013
Levis JT, Sam DL. Images in emergency medicine: phlegmasia cerulea dolens. Perm J. 2013; 17(1):68. PMID: 23596373.